Chris Weyrer
Venture Capital Life Science Professional Vida Ventures
Seminars
Wednesday 16th September 2026
Panel Discussion: Neuropsychiatry at a Crossroads: Where Science, Strategy & Deal Making Converge
9:45 am
- What indications are you excited about and actively exploring?
- Which drug modalities are you excited about and actively exploring?
- In 2026 are we ready for precision psychiatry, and what might we need to improve in terms of diagnostics to get there (genetics, etc.)?
Wednesday 16th September 2026
Panel Discussion: Future Directions & Strategic Investment to Fuel the Next Wave of Neuropsychiatric Therapeutics
4:45 pm
- How emerging scientific modalities such as circuit level biomarkers, data integrated platforms, and next generation neuroplastogens are shaping the future landscape of neuropsychiatric innovation
- What investors and R&D leaders look for in early stage assets, including differentiated mechanisms, strong biomarker strategies, and clear pathways to clinical and commercial de risking
- How strategic capital allocation across discovery, translational technologies, and Phase 2/3 ready programs can build sustainable, multi mechanism therapeutic pipelines
- Where the field is heading next, and how cross disciplinary innovation and coordinated investment can accelerate the next transformative wave in neuropsychiatric therapeutics
